Somna Therapeutics LLC today announced that the U.S. Food and Drug Administration (FDA) has cleared the Reza Band as the first over-the-counter device of its kind for the reduction or elimination of laryngopharyngeal reflux (LPR) symptoms
The clinically-proven Reza Band provides relief from LPR symptoms by applying slight external pressure to the cricoid cartilage area located below the Adam’s apple, which increases the internal pressure of the UES. The device reduces challenging symptoms such as chronic throat irritation and cough, hoarse voice, difficulty swallowing, and postnasal drip. The Reza Band was founded on scientific and clinical research conducted over 20 years by a leading gastroenterologist at the Medical College of Wisconsin.
About Laryngopharyngeal Reflux (LPR) Disease
Millions of people suffer from laryngopharyngeal reflux (LPR) disease. Those who suffer from this disease have a dysfunctional upper esophageal sphincter (UES). A poorly functioning UES results in regurgitation of stomach contents from the esophagus up and into the larynx, pharynx and lungs. This can cause health issues such as chronic throat irritation, cough, hoarse voice, asthma, difficulty swallowing, postnasal drip, pneumonia and sleep disruption. Alternate treatments include lifestyle modification, drug therapy and surgery.
Source: www.rezaband.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180501006341/en/
Contacts
Somna Therapeutics LLC
Laura Jackson
VP Sales and Marketing
262-345-5553, ext. 104
Source: Somna Therapeutics LLC